{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:08:20Z","timestamp":1793156900510,"version":"4.5.0"},"reference-count":17,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,8,24]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Familial hypocalciuric hypercalcaemia (FHH) is a rare disorder that represents a minute but important part of the differential diagnosis of hypercalcaemia. We describe a man in his 60s who was re-referred to endocrinology because of hypercalcaemia thought to be due to primary hyperparathyroidism (PHPT) that had not been followed up for 13 years. In his early 50s, the hypercalcaemia was accompanied by normal serum parathyroid hormone (PTH) levels, normal 24-hour urinary calcium excretion and normal bone density and kidney imaging, and no parathyroid adenoma was demonstrated on neck imaging. He declined further tests and follow-up. Repeat PTH and 24-hour urinary calcium excretion were still normal, but a low calcium-creatinine clearance ratio prompted genetic testing for FHH. This was positive for a rare mutation in the calcium-sensing receptor gene, and a diagnosis of FHH type 1 was made. This case highlights the differential diagnosis of hypercalcaemia and the challenges in differentiating FHH and PHPT.<\/jats:p>","DOI":"10.1136\/bcr-2025-266308","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:40:27Z","timestamp":1757479227000},"page":"e266308","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Familial hypocalciuric hypercalcaemia type 1 due to a rare <i>CASR<\/i> missense mutation: a delayed diagnosis in a man with chronic hypercalcaemia"],"prefix":"10.1136","volume":"18","author":[{"given":"Hsu Yee","family":"Mon","sequence":"first","affiliation":[{"name":"Medicine, North West Anglia NHS Foundation Trust, Peterborough, Cambridgeshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7849-4029","authenticated-orcid":false,"given":"Nwe Ni","family":"Win","sequence":"additional","affiliation":[{"name":"Medicine, North West Anglia NHS Foundation Trust, Peterborough, Cambridgeshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4104-9674","authenticated-orcid":false,"given":"Samson Oghenetsovwe","family":"Oyibo","sequence":"additional","affiliation":[{"name":"Diabetes and Endocrinology, North West Anglia NHS Foundation Trust, Peterborough, Cambridgeshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"2025090921402170000_18.9.e266308.1","first-page":"1959","article-title":"A practical approach to hypercalcemia","volume":"67","author":"Carroll","year":"2003","journal-title":"Am Fam Physician"},{"key":"2025090921402170000_18.9.e266308.2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2723","article-title":"The diagnosis and management of hypercalcaemia","volume":"350","author":"Minisola","year":"2015","journal-title":"BMJ"},{"key":"2025090921402170000_18.9.e266308.3","unstructured":"National Institute for Health and Care Excellence (NICE) . Hyperparathyroidism (primary): diagnosis, assessment and initial management. NICE; 2019. Available: www.nice.org.uk\/guidance\/ng132"},{"key":"2025090921402170000_18.9.e266308.4","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4677"},{"key":"2025090921402170000_18.9.e266308.5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.beem.2018.05.004","article-title":"Familial hypocalciuric hypercalcemia and related disorders","volume":"32","author":"Lee","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2025090921402170000_18.9.e266308.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300253"},{"key":"2025090921402170000_18.9.e266308.7","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2492"},{"key":"2025090921402170000_18.9.e266308.8","doi-asserted-by":"crossref","DOI":"10.1210\/jcemcr\/luae096","article-title":"Two Cases of Symptomatic Familial Hypocalciuric Hypercalcemia: Treatment Response to Calcimimetic Therapy","volume":"2","author":"Shakesprere","year":"2024","journal-title":"JCEM Case Rep"},{"key":"2025090921402170000_18.9.e266308.9","article-title":"Recurrent pancreatitis in a patient with familial hypocalciuric hypercalcaemia treated successfully with cinacalcet","volume":"2014","author":"Gunganah","year":"2014","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"2025090921402170000_18.9.e266308.10","article-title":"A novel CASR variant in a family with familial hypocalciuric hypercalcaemia and primary hyperparathyroidism","volume":"2020","author":"Sagi","year":"2020","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"2025090921402170000_18.9.e266308.11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020249"},{"key":"2025090921402170000_18.9.e266308.12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1739"},{"key":"2025090921402170000_18.9.e266308.13","article-title":"A Case of Lithium-Associated Hypocalciuric Hypercalcemia","volume":"12","author":"Nwabufor","year":"2020","journal-title":"Cureus"},{"key":"2025090921402170000_18.9.e266308.14","first-page":"361","article-title":"Familial Hypocalciuric Hypercalcemia and Benefits of Genetic Confirmation: A Case Report and Review","volume":"3","author":"Jalilian","year":"2017","journal-title":"AACE Clin Case Rep"},{"key":"2025090921402170000_18.9.e266308.15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1308\/rcsann.2021.0333","article-title":"Excluding familial hypocalciuric hypercalcaemia before surgery for primary hyperparathyroidism - a practical evaluation of urinary calcium using a retrospective cohort design","volume":"104","author":"McAllister","year":"2022","journal-title":"Ann R Coll Surg Engl"},{"key":"2025090921402170000_18.9.e266308.16","doi-asserted-by":"publisher","DOI":"10.4158\/EP12284.RA"},{"key":"2025090921402170000_18.9.e266308.17","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JME-19-0104","article-title":"Molecular and clinical insights from studies of calcium-sensing receptor mutations","volume":"63","author":"Gorvin","year":"2019","journal-title":"J Mol Endocrinol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-266308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:40:29Z","timestamp":1757479229000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-266308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":17,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,9]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bcr-2025-266308"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-266308","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}